Position in JANX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$34,249,836
-$18,934,687 QoQ
Shares Held
2,464,017
-36.1% QoQ
Ownership
4.04%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 10%
Shared 0%
None 90%
Common Shares in JANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,288,856,014 across 423 Biotechnology names. JANX ranks #120 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in JANX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $34,249,836 | 2,464,017 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $34,249,836 | 2,464,017 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $53,184,523 | 3,853,951 | Shares | Sole | 2026-02-09 | |
| 2025-12-31 | $53,184,523 | 3,853,951 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $46,227,404 | 1,891,465 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $32,065,294 | 1,388,108 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $37,030,419 | 1,371,497 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $67,885,989 | 1,267,949 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $61,838,316 | 1,361,178 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $58,697,692 | 1,401,234 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $15,039,932 | 399,467 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,729,587 | 347,585 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,342,235 | 331,571 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,947,843 | 332,590 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,613,410 | 298,629 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,728,558 | 283,110 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $3,577,362 | 264,207 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $3,223,708 | 264,022 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,470,251 | 241,998 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,174,197 | 211,566 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,777,549 | 174,644 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||